IRIS
LATELLA, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.947
EU - Europa 13.458
AS - Asia 12.506
SA - Sud America 1.400
AF - Africa 128
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 22
AN - Antartide 1
Totale 48.485
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.712
SG - Singapore 4.648
CN - Cina 3.387
IE - Irlanda 2.713
IT - Italia 2.689
RU - Federazione Russa 2.389
TR - Turchia 1.685
DE - Germania 1.305
BR - Brasile 1.220
HK - Hong Kong 1.131
VN - Vietnam 947
FR - Francia 909
UA - Ucraina 898
GB - Regno Unito 867
SE - Svezia 681
FI - Finlandia 592
IN - India 232
CA - Canada 130
JP - Giappone 106
NL - Olanda 94
BD - Bangladesh 71
AR - Argentina 70
MX - Messico 67
CZ - Repubblica Ceca 55
IQ - Iraq 47
BE - Belgio 45
ES - Italia 45
ZA - Sudafrica 45
PL - Polonia 44
ID - Indonesia 34
SA - Arabia Saudita 28
AT - Austria 25
EC - Ecuador 23
CL - Cile 22
EU - Europa 21
AE - Emirati Arabi Uniti 19
CO - Colombia 19
KE - Kenya 17
TN - Tunisia 17
RO - Romania 16
VE - Venezuela 16
AU - Australia 15
IL - Israele 15
LT - Lituania 14
MA - Marocco 14
PH - Filippine 14
PK - Pakistan 14
UZ - Uzbekistan 14
BG - Bulgaria 12
JO - Giordania 11
MY - Malesia 11
NP - Nepal 10
PY - Paraguay 10
CH - Svizzera 9
OM - Oman 9
TH - Thailandia 9
PE - Perù 8
EE - Estonia 7
EG - Egitto 7
KR - Corea 7
TT - Trinidad e Tobago 7
UY - Uruguay 7
AL - Albania 6
CR - Costa Rica 6
KZ - Kazakistan 6
LB - Libano 6
NZ - Nuova Zelanda 6
PT - Portogallo 6
AZ - Azerbaigian 5
DZ - Algeria 5
HU - Ungheria 5
JM - Giamaica 5
KG - Kirghizistan 5
PS - Palestinian Territory 5
AO - Angola 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
AM - Armenia 3
BH - Bahrain 3
BO - Bolivia 3
CG - Congo 3
GE - Georgia 3
HN - Honduras 3
IR - Iran 3
LU - Lussemburgo 3
QA - Qatar 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
SM - San Marino 3
SN - Senegal 3
TW - Taiwan 3
BB - Barbados 2
BY - Bielorussia 2
GA - Gabon 2
IM - Isola di Man 2
IS - Islanda 2
LV - Lettonia 2
MD - Moldavia 2
MN - Mongolia 2
MT - Malta 2
Totale 48.443
Salva come PNG Salva come JPEG
Città #
Jacksonville 3.357
Dublin 2.705
Singapore 2.634
Chandler 2.490
Dallas 1.853
San Jose 1.768
Ashburn 1.150
Hong Kong 1.112
Boardman 1.082
Santa Clara 1.051
Izmir 850
Nanjing 756
San Mateo 641
The Dalles 561
Wilmington 488
New York 457
Lawrence 452
Princeton 450
Moscow 425
Beijing 384
Lauterbourg 342
Dearborn 331
Ho Chi Minh City 298
Milan 260
Ann Arbor 234
Hanoi 229
Nanchang 229
Hangzhou 201
Council Bluffs 181
Hefei 165
Munich 161
L’Aquila 158
Rome 146
Los Angeles 145
Kunming 132
São Paulo 126
Tianjin 123
Shenyang 121
Seattle 120
Verona 111
Helsinki 108
Hebei 103
Frankfurt am Main 100
Jiaxing 95
L'aquila 91
Tokyo 89
Mountain View 88
Des Moines 85
Jinan 84
Woodbridge 79
Ningbo 64
Bremen 63
Changsha 62
Norwalk 61
Turku 56
Zhengzhou 56
Guangzhou 53
Brno 47
Shanghai 47
London 45
Da Nang 44
Brussels 43
Lappeenranta 42
Orem 42
Montreal 41
Stockholm 41
Columbus 38
Toronto 38
Belo Horizonte 37
Haiphong 36
Warsaw 36
Amsterdam 34
Denver 33
Napoli 33
Phoenix 33
Chicago 32
Mumbai 32
Rio de Janeiro 31
Berlin 30
Dong Ket 30
Pescara 29
Pune 29
Atlanta 28
Brasília 28
Brooklyn 28
Poplar 28
Boston 27
Falkenstein 27
Lanzhou 27
Taizhou 27
Chennai 26
Houston 26
Naples 26
Johannesburg 25
Mexico City 24
Manchester 23
Changchun 22
Nuremberg 22
Palermo 20
San Francisco 20
Totale 31.193
Salva come PNG Salva come JPEG
Nome #
Iperplasia follicolare linfatica dell'intestino tenue. 1.830
Efficacia di un nuovo preparato di olio di pesce sulla recidiva del Morbo di Crohn. Giornale di Gastroenterologia 1996;1:158-162 333
Cellular and molecular mechanisms of intestinal fibrosis 273
The Relationship Between Nutritional Status, Micronutrient Deficiency, and Disease Activity in IBD Patients: A Multicenter Cross-Sectional Study 247
Subtypes of chronic gastritis in patients with celiac disease before and after gluten-free diet 177
Role of glycogen synthase kinase-3β and PPAR-γ on epithelial-to-mesenchymal transition in DSS-induced colorectal fibrosis 175
Effetti del butirrato sui colonociti umani 173
Non-Celiac Gluten Sensitivity among Patients Perceiving Gluten-Related Symptoms 163
Histological healing in ulcerative colitis with mesalazine and its prognostic role 159
IgG4-Related Disease Mimicking Crohn's Disease: A Case Report and Review of Literature 156
PPAR-gamma improves intestinal fibrosis by targeting the EMT-activator ZEB1. 155
Subtypes of chronic gastritis in patients with coeliac disease before and after gluten-free diet 153
Epithelial-to-Mesenchymal Transition (EMT) in experimental intestinal fibrosis 152
Low HtrA1 expression in patients with long-standing ulcerative colitis and colorectal cancer 152
Increased proliferation and apoptosis of colonic epithelial cells in Dextran Sulphate Sodium – induced colitis in rats 151
Association between colonic diverticula and colorectal polyps and cancer 149
Surrogate Fecal Biomarkers in Inflammatory Bowel Disease: Rivals or Complementary Tools of Fecal Calprotectin? 149
Mastocytic enterocolits and the role of mast cells in functional and inflammatory intestinal disorders: A systematic review 149
The prognostic value of histology in ulcerative colitis in clinical remission with mesalazine 146
Lymphocytic gastritis is present in Celiac Disease and improves after gluten-free diet. 145
Risk of colonoscopic post-polypectomy bleeding in patients on single antiplatelet therapy: systematic review with meta-analysis 145
Association between colorectal polyps and colonic diverticulosis 142
Metabolic Alterations in Celiac Disease Occurring after Following a Gluten-Free Diet 140
The Charming World of the Extracellular Matrix: A Dynamic and Protective Network of the Intestinal Wall 140
Ferroptosis resistance cooperates with cellular senescence in the overt stage of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 139
Clinical course of Crohn's disease first diagnosed at surgery for acute abdomen. 139
Novel PPARgamma modulator GED-0507-34 Levo ameliorates Inflammation driven intestinal fibrosis. 138
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 138
Prevention of colonic fibrosis by Boswellia and Scutellaria extracts in rats with colitis induced by 2,4,5-trinitrobenzene sulphonic acid 135
Malassorbimenti intestinali e reazioni avverse agli alimenti in gravidanza. Giornale di gastroenterologia 2004;9:7-14 135
Non-steroidal anti-inflammatory drugs and acetylsalicylic acid increase the risk of complications of diverticular disease: a meta-analysis of case–control and cohort studies 135
Acido lattico fecale e diarrea nella colite ulcerosa 134
Prolonged chronic consumption of a high fat with sucrose diet alters the morphology of the small intestine 134
The angiotensin receptor blocker, losartan, reduces inflammation and fibrosis, and prevents relapse of fibrosis after steroid-induced remission, in mice prone to Crohn's disease-like ileitis 133
Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice 133
Metabolismo dell'epitelio colico e neoplasie colorettali 132
Bacterial Lysate from the Multi-Strain Probiotic SLAB51 Triggers Adaptative Responses to Hypoxia in Human Caco-2 Intestinal Epithelial Cells under Normoxic Conditions and Attenuates LPS-Induced Inflammatory Response 132
Role of urinary biomarkers in the diagnosis of adenoma and colorectal cancer: A systematic review and meta-analysis 131
Sleep disorders related to nutrition and digestive diseases: A neglected clinical condition 131
PPAR-Gamma coordinates EMT, AGE, and senescence signaling and mitigates the intestinal fibrosis in IBDs 130
Small bowel carcinomas in coeliac or Crohn's disease: Clinico-pathological, molecular, and prognostic features. A study from the small bowel cancer Italian consortium 130
Mouse Sertoli cells sustain de novo generation of regulatory T cells by triggering the notch pathway through soluble JAGGED1. 129
Can Nrf2 modulate the development of intestinal fibrosis and cancer in inflammatory bowel disease? 129
Association between corrected QT interval and C-reactive protein in patients with inflammatory bowel diseases 129
Has infliximab influenced the course and prognosis of acute severe ulcerative colitis? 129
Smad3 loss confers resistance to the development to trinitrobenzene sulphonic acid-induced colorectal fibrosis 127
Dietary components that counteract the increased risk of colorectal cancer related to red meat consumption 126
GI distension in severe ulcerative colitis 125
Persistent iron deficiency anemia in patients with celiac disease despite a gluten-free diet 125
Inflammatory bowel disease: New insights into the interplay between environmental factors and pparγ 125
Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodology 125
Increased prevalence of Helicobacter pylori in patients with diabetes mellitus 124
Il 5-ASA (Asacol) previene le recidive post-operatorie del morbo di Crohn. Risultati dello studio GISC a tre anni di follow-up. 124
Fecal Lactoferrin and Other Putative Fecal Biomarkers in Crohn's Disease: Do They Still Have a Potential Clinical Role? 124
La calprotectina fecale nei pazienti con malattie infiammatorie intestinali. Giornale di Gastroenterologia 2002;7:152-155 123
Expression of pro-fibrotic and anti-fibrotic molecules in dimethylnitrosamine-induced hepatic fibrosis 123
Vaccine Acceptance in Patients with Inflammatory Bowel Disease: Lessons Learned from the COVID-19 Pandemic 123
Effects of SCFA on human colonocytes. Gastroenterology International 1998;11:76-79 122
Are volatile organic compounds accurate markers in the assessment of colorectal cancer and inflammatory bowel diseases? A review 122
Systematic review and meta-analysis: the advantage of endoscopic Mayo score 0 over 1 in patients with ulcerative colitis 122
The role of new inflammatory indices in the prediction of endoscopic and histological activity in inflammatory bowel disease patients 121
Is mastocytic colitis a specific clinical-pathological entity? 121
Le derivazioni urinarie interne: condizioni a rischio di complicanze neoplastiche e metaboliche. 121
Diarree. In: Manuale di Gastroenterologia - UNIGASTRO (Coordinamento Nazionale dei Docenti Universitari di Malattie dell’Apparato Digerente), EGI Editrice, Edizione 2004-2006, Roma, EGI Editrice, 2004:45-55 121
Predictive value of the Diverticular Inflammation and Complication Assessment (DICA) endoscopic classification on the outcome of diverticular disease of the colon: An international study 121
Is fecal calprotectin an accurate marker in the management of Crohn's disease? 121
Prognostic factors for postoperative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC) 120
The usefulness of serum vitamin D levels in the assessment of IBD activity and response to biologics 120
Colite acuta dopo colonscopia. Giornale di Gastroenterologia 1997; 2: 88-93 119
Mucosal healing: Mayo 0 vs 1 after 3 years. 119
Mastocytic enterocolitis: Increase of mast cells in the gastrointestinal tract of patients with chronic diarrhea 119
Struttura e funzioni dell’intestino tenue. Giornale di gastroenterologia 2002;7:99-106 118
La terapia medica delle emorragie digestive alte. Atti della XI Riunione Scientifica dell'Associazione Chirurghi Regione-Abruzzo, Avezzano (AQ), 27 Aprile 1985:p. 93-97 118
Boswellia serrata and Salvia miltiorrhiza extracts reduce DMN-induced hepatic fibrosis in mice by TGF-β1 downregulation 118
Topical Aminosalicylates and Histologic Healing in Ulcerative Colitis 118
Current management of severe ulcerative colitis. 118
Celiac disease, gluten-free diet, and metabolic and liver disorders 117
Site and duration of abdominal pain discriminate symptomatic uncomplicated diverticular disease from previous diverticulitis patients 116
Bowel movement alterations predict the severity of diverticular disease and the risk of acute diverticulitis: a prospective, international st 116
Role of nitric oxide in the impairment of circular muscle contractility of distended, uninflamed mid-colon in TNBS-induced acute distal colitis in rats 116
Electrolyte and acid base imbalance in patients with rectosigmoid bladder. 116
Morbo di Crohn: elettroliti fecali e equilibrio acido-base in rapporto alla sede delle lesioni. 116
Trattamento dell'acalasia con iniezione intrasfinterica di tossina botulinica. Giornale di Gastroenterologia 1997; 2: 94-97 115
Nutrizione enterale. Giornale di gastroenterologia 2003;8:90-102 115
Espressione dell’anidrasi carbonica 1 nella mucosa colica di pazienti con colite ulcerosa. 115
PPAR-Gamma Orchestrates EMT, AGE, and Cellular Senescence Pathways in Colonic Epithelium and Restrains the Progression of IBDs 114
Anastomotic configuration and mucosal 5-aminosalicylic acid (5-ASA) concentrations in patients with Crohn's Disease: a GISC study 114
GED-0507-34 Levo, a novel modulator of PPARgamma as new therapeutic strategy in the treatment of intestinal fibrosis 114
PPAR-γ with its anti-inflammatory and anti-fibrotic action could be an effective therapeutic target in IBD 114
TNBS colitis induces architectural changes and alpha-synuclein overexpression in mouse distal colon: A morphological study 113
Survival and causes of death in Italian patients with ulcerative colitis. A GISC nation-wide study. 113
Association of colonic diverticula with colorectal adenomas and cancer 113
Rapporto del III Congresso Nazionale della Federazione Italiana di Colonproctologia (FICP). 112
The antiinflammatory and antifibrotic effect of olive phenols and Lactiplantibacillus plantarum IMC513 in dextran sodium sulfate–induced chronic colitis 112
Analisi clinica di una combinazione di markers oncologici nel carcinoma colorettale. Chirurgia Generale – General Surgery 1988;IX:453-457 111
Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon. 111
Ulcerative colitis and multiple organ dysfunction syndrome (MODS). 111
Quando il colon diventa vescica. 111
Nanotechnology in the treatment of inflammatory bowel diseases. 111
Vitamin D in Inflammatory Bowel Diseases. Mechanisms of Action and Therapeutic Implications 111
Totale 15.049
Salva come PNG Salva come JPEG
Categoria #
all - tutte 187.843
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 187.843
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.083 0 0 0 0 0 0 0 0 0 114 847 122
2021/20222.263 79 288 257 101 117 36 30 184 161 81 194 735
2022/20237.651 563 252 146 707 788 822 7 522 3.457 44 226 117
2023/20242.179 415 114 88 332 134 403 58 327 11 45 87 165
2024/20257.712 152 145 836 207 765 681 835 744 1.755 587 507 498
2025/202614.008 577 1.419 1.112 1.928 1.187 1.330 2.763 641 1.471 1.580 0 0
Totale 48.863